Get Paid For Watching - Sign Up Now - FREE!
Username:    Password:    
WallSt TV WallSt.net Mywallst WallSt Radio
Home Exclusives News Interviews Podcasts Tools Forums Rookies Shop
Home My Profile Join Browse Search Mail Blogs Forum Rookies Login
Home 3 Minute Press Show News Magazine Analyst's Review Sweet Picks Conference Coverage Login
Home Search Podcasts Submit a Podcast Contact Us Login
Featured Show
This video was published 51 Days 3 Hours 31 Mins ago.

Premium Access: Available NOW
Member Access: Available NOW
Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.

The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.

Members are encouraged to ask these executives questions through their message boards at Mywallst

3 Minute Press Show - Thursday, May 15, 2008
Loading..
Featured Company:
Ambrilia Biopharma, Inc.

Exchange:
International - TSX

Ticker:
AMB

Interviewee:
Dr. Philippe Calais
President & CEO

Back to Full Show
Ambrilia Biopharma, Inc. (AMB)

Ambrilia Biopharma Inc. is a biotechnology company focused on the discovery and development of novel treatments for viral diseases and cancer. In the latter part of 2007, Ambrilia adopted a new strategic plan, the primary objective of which is to progressively refocus R&D activities solely on antivirals. The strategy aims to capitalize on the Company's broad portfolio and original expertise in virology. Today, Ambrilia's product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a therapeutic peptide for prostate cancer, a targeted delivery platform for cancer, a HIV protease inhibitor program (exclusive worldwide rights granted to Merck & Co., Inc.), HIV integrase inhibitor and entry inhibitor programs, and a HCV polymerase inhibitor program. Ambrilia's head office, research and development and manufacturing facilities are located in Montreal with a regional office in France. For more information, please visit the Company's web site: www.ambrilia.com.



For more advance tools and analysis, visit the Tools page.

Comments News Level II Profile Financials Insiders Filings


  User Comments

0
Bulls
   0
Bears
     






Be the first to comment on
Ambrilia Biopharma, Inc. (International - TSX: AMB)





Comment on Ambrilia Biopharma, Inc.
Please log in to post a comment.
Username:    Password:  

Don't have an account? 

Featured Companies
Vidshadow, Inc.
Jordan Hudgens
CEO
Monday, June 30, 2008

Founded in 2006 by CEO Jordan Hudgens and based in Orange County, CA, Vidshadow is one of the Internet's fastest growing video distribution networks providing solutions to advertisers, content provide...

Vidshadow, Inc.

Jordan Hudgens
CEO
Monday, May 5, 2008

Founded in 2006 by CEO Jordan Hudgens and based in Orange County, CA, Vidshadow, Inc. is one of the Internet’s fastest growing video distribution networks providing solutions to advertisers, content p...

China YouTV Corporation

Angela Du
Manager of Public Relations
Monday, April 7, 2008

Established in May 2005, and further funded by HuaJu Network in July 2006, CnBoo.com developed from a simple video network site, to become the leader in online video and the premier destination to w...



Latest Episodes
3 Minute Press Show  - 07.02.08
Mariner's Choice International, Inc., Alseres Pharmaceuticals, Inc., American Marketing & Sales dba Innovative designs, a wholly owned subsidiary of Datameg Corp., Check Point® Software Technologies, Ltd.
3 Minute Press Show  - 07.01.08
J.D. Power & Associates a business unit of The McGraw-Hill Companies, interCLICK, Inc., Domino's Pizza Inc., Franklin Mining, Inc.
3 Minute Press Show  - 06.30.08
Tao Minerals, Ltd., Physicians Adult Daycare, Inc., Mediware Information Systems, Inc., Global 8 Environmental Technologies, Inc., Vidshadow, Inc.
3 Minute Press Show  - 06.27.08
Accelrys, Inc., Endwave Corp., Kiwa Bio-Tech Products Group Corp., Zevotek, Inc.
3 Minute Press Show  - 06.26.08
Compuware Corporation, Lantis Laser, Inc., Autodesk, Inc., Aperture Health, Inc., Avasant, Green Star Products, Inc.


HOME | SUPPORT | EDITORIAL | CONFLICT POLICY | TERMS OF USE | CONDITIONS OF USE | PRIVACY POLICY | DISCLAIMER | SERVICES | CONTACT US |

©2008 WallSt TV All Rights Reserved.
The views and ideas expressed in the videos on this site do not necessarily reflect those of WallSt TV or its affiliates.